Comparative in vitro activity of nine antistaphylococcal agents against 275 recent isolates of Gram-positive cocci

被引:4
|
作者
Ravaoarinoro, M
Therrien, C
机构
[1] HOSP HOTEL DIEU,DEPT MICROBIOL & INFECT DIS,MONTREAL,PQ,CANADA
[2] UNIV MONTREAL,DEPT MICROBIOL & IMMUNOL,MONTREAL,PQ H3C 3J7,CANADA
关键词
in vitro activity; antimicrobial agents; Gram positive cocci; RESISTANT STAPHYLOCOCCUS-AUREUS; TEICHOMYCETICUS-NOV-SP; TEICOPLANIN; ENTEROCOCCI; VANCOMYCIN;
D O I
10.1016/S0924-8579(96)00317-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to compare the in vitro activities of 9 antistaphylococcal agents including teicoplanin (TEI) against 275 non-repetitive clinical strains representing 15 species of staphylococci and 27 strains of Enterococcus (E.) faecalis, isolated from various specimens between 1991-1992 at a Canadian teaching hospital. The NCCLS agar dilution method was used (10(4) colony-forming units/spot). In terms of MIC(90), TEI and vancomycin (VAN) appeared to be the most potent antibiotics against all staphylococci tested (TEI: 2.0-4.0 mu g/ml; VAN: 1.0-2.0 mu g/ml; ciprofloxacin (CPF): 0.25-32 mu g/ml; cefazolin (CEF): 8.0-256 mu g/ml; methicillin (MET): 2.0->256 mu g/ml; imipenem (IMP): 1.0-32 mu g/ml; erythromycin (ERT): 16->256 mu g/ml; ampicillin (AMP): 16-128 mu g/ml; fusidic acid (FSA): 0.5-16 mu g/ml). Multiple resistant strains, including MET-resistant Staphylococcus (Staph.) aureus and Staph. epidermidis, were susceptible to TEI and VAN with respective MICs of 2-4 mu g/ml and 1-2 mu g/ml regardless of specimen type. Moreover, TEI was highly active against E. faecalis (MIC(90) for TEI and VAN: 0.5 and 4.0 mu g/ml, respectively).
引用
收藏
页码:167 / 170
页数:4
相关论文
共 50 条
  • [31] Comparative In Vitro Activity of Trovafloxacin Against Gram-Positive and Gram-Negative Clinical Isolates from Argentina
    Adriana Sucari
    D. Stepanik
    J. M. Casellas
    G. Tomé
    L. Clara
    M. Marín
    A. Rossi
    M. Galas
    J. Smayevsky
    L. Dufranc
    H. Lorenzo
    L. de Vedia
    H. López
    Drugs, 1999, 58 : 195 - 199
  • [32] Comparative in vitro activity of trovafloxacin against Gram-positive and Gram-negative clinical isolates from Argentina
    Sucari, A
    Stepanik, D
    Casellas, JM
    Tomé, G
    Clara, L
    Marín, M
    Rossi, A
    Galas, M
    Smayevsky, J
    Dufranc, L
    Lorenzo, H
    de Vedia, L
    López, H
    DRUGS, 1999, 58 (Suppl 2) : 195 - 199
  • [33] In vitro activity of novel rifamycins against gram-positive clinical isolates
    Murphy, Christopher K.
    Karginova, Elena
    Sahm, Dan
    Rothstein, David M.
    JOURNAL OF ANTIBIOTICS, 2007, 60 (09): : 572 - 576
  • [34] Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against Gram-positive cocci
    Coque, TM
    Singh, KV
    Murray, BE
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) : 1011 - 1016
  • [35] In the wings: Ketolides against gram-positive cocci
    Gorbach, SL
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1998, 7 (06) : 249 - 249
  • [36] IN-VITRO ACTIVITY OF SPARFLOXACIN, CIPROFLOXACIN, OFLOXACIN, AND OTHER ANTIBIOTICS AGAINST BLOOD-STREAM ISOLATES OF GRAM-POSITIVE COCCI
    ROTSTEIN, C
    AMSTERDAM, D
    BEAM, TR
    MANDELL, LA
    GORZYNSKI, EA
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1993, 17 (01) : 85 - 91
  • [37] In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci
    Giacometti, Andrea
    Cirioni, Oscar
    Riva, Alessandra
    Kamysz, Wojciech
    Silvestri, Carmela
    Nadolski, Piotr
    Della Vittoria, Agnese
    Lukasiak, Jerzy
    Scalise, Giorgio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1494 - 1496
  • [38] In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci
    Fluit, AC
    Schmitz, FJ
    Verhoef, J
    Milatovic, D
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (02) : 271 - 276
  • [39] Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates
    Sader, Helio S.
    Fritsche, Thomas R.
    Jones, Ronald N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 2171 - 2175
  • [40] ACTIVITY OF VANCOMYCIN AGAINST RECENTLY ISOLATED NOSOCOMIAL GRAM-POSITIVE COCCI
    MACCANTI, O
    BONADIO, M
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1992, 18 (07) : 295 - 297